Table 1. KLF6 Genotype and NAFLD related associations in normal individuals.
KLF6 | Linear Trend | AA vs AG+GG | AA+AG vs GG | |||
---|---|---|---|---|---|---|
AA | GA | GG | ||||
Number | 12 | 155 | 1082 | |||
Age (years) | 42.08±2.95 | 45.74±0.68 | 43.57±0.25 | na | ns | 0.006 |
Sex (M:F)* | 6:6 | 71:84 | 481:599 | na | ns | ns |
BMI | 23.72±1.29 | 25.97±0.33 | 25.53±0.12 | ns | ns | ns |
Fat mass (kg/m2) | 15.43±2.37 | 22.12±0.75 | 20.94±0.27 | ns | 0.023 | ns |
Glucose (mmol/l) | 4.79±0.20 | 5.01±0.05 | 5.08±0.02 | 0.003 | ns | 0.009 |
FPI (pmol/l) | 20.21±3.47 | 31.36±1.51 | 32.86±0.68 | 0.022 | ns(0.050) | ns |
HOMA-IR | 0.95±0.14 | 1.37±0.07 | 1.36±0.03 | ns | ns | ns |
OGIS | 486.1±19.7 | 442.8±5.11 | 441.5±2.04 | 0.042 | ns | ns |
M/I μmol min−1 (kg fat-free mass)−1 nmol−1 | 159.8±25.6 | 143.5±5.48 | 137.7±2.21 | ns | ns | ns |
icl_OGTT (l/min/m2) | 2.20±0.29 | 1.65±0.65 | 1.62±0.0.56 | ns | 0.015 | ns |
TG (mmol/l) | 79.00±7.92 | 110.05±6.09 | 107.40±2.23 | ns | ns | ns |
WC (cm) | 82.41±4.76 | 87.70±1.01 | 86.58±0.38 | ns | ns | ns |
KLF6 | Linear Trend | AA vs AG+GG | AA+AG vs GG | |||
---|---|---|---|---|---|---|
AA | GA | GG | ||||
Number | 5 | 38 | 327 | |||
Age (years) | 36.40±2.65 | 45.76±1.49 | 42.75±8.08 | na | ns | ns |
Sex (M:F)* | 5:0 | 17:21 | 163:164 | na | ns | ns |
BMI | 25.04±1.67 | 27.00±0.62 | 26.01±0.23 | na | ns | ns |
Fat_mass (kg/m2) | 14.14±3.38 | 23.26±1.47 | 21.51±0.51 | na | ns | ns |
Glucose (mmol/l) | 4.72±0.14 | 4.93±0.08 | 4.99±0.03 | 0.027 | ns | ns |
FPI (pmol/l) | 18.54±3.33 | 26.50±2.52 | 30.98±1.23 | 0.005 | ns | 0.015 |
EGP | 17.06±2.34 | 16.33±0.79 | 16.36±0.26 | ns | ns | ns |
Hepatic Insulin Resistance | 343.46±101.9 | 422.30±44.3 | 496.29±19.1 | 0.022 | ns | 0.029 |
Key: BMI – Body Mass Index; HOMA-IR – homeostatic model assessment of insulin resistance; OGIS – ‘oral glucose insulin sensitivity’ index; M/I – whole-body insulin sensitivity measured by hyperinsulinaemic clamp; FPI – Fasting Plasma Insulin; TG – triglycerides; WC – waist circumference; GCR_b – Basal glucose clearance (production/concentration); icl_OGTT – endogenous ‘pre-hepatic’ clearance during OGTT. ns: not significant; na: not appropriate; KW-Kruskal Wallis test.